Literature DB >> 29388096

Activation-Induced Cytidine Deaminase Aided In Vitro Antibody Evolution.

Lili An1, Chuan Chen1, Ruiqi Luo1, Yun Zhao1, Haiying Hang2.   

Abstract

Activation-induced cytidine deaminase (AID) initiates somatic hypermutation (SHM) by converting deoxycytidines (dC) to deoxyuracils (dU) which then can induce other mutations, and plays a central role in introducing diversification of the antibody repertoire in B cells. Ectopic expression of AID in bacteria and non-B cells can also lead to frequent mutations in highly expressed genes. Taking advantage of this feature of AID, in recent years, systems coupling in vitro somatic hypermutation and mammalian cell surface display have been developed, with unique benefits in antibody discovery and optimization in vitro. Here, we provide a protocol for AID mediated in vitro protein evolution. A CHO cell clone bearing a single gene expression cassette has been constructed. The gene of an interested protein for in vitro evolution can be easily inserted into the cassette by dual recombinase-mediated cassette exchange (RMCE) and constantly expressed at high levels. Here, we matured an anti-TNFα antibody as an example. Firstly, we obtained a CHO cell clone highly displaying the antibody by dual RMCE. Then, the plasmid expressing AID is transfected into the CHO cells. After a few rounds of cell sorting-cell proliferation, mutant antibodies with improved features can be generated. This protocol can be applied for improving protein features based on displaying levels on cell surface and protein-protein interaction, and thus is able to enhance affinity, specificity, and stability besides others.

Entities:  

Keywords:  Activation-induced cytidine deaminase (AID); Affinity maturation; Antibody evolution; Somatic hypermutation (SHM)

Mesh:

Substances:

Year:  2018        PMID: 29388096     DOI: 10.1007/978-1-4939-7474-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies.

Authors:  Marie-Claire Devilder; Melinda Moyon; Laetitia Gautreau-Rolland; Benjamin Navet; Jeanne Perroteau; Florent Delbos; Marie-Claude Gesnel; Richard Breathnach; Xavier Saulquin
Journal:  BMC Biotechnol       Date:  2019-02-18       Impact factor: 2.563

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.